Annual EPS
-$3.00
$0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual earnings per share is -$3.00, unchanged on December 31, 2023.
- During the last 3 years, CANF annual EPS has risen by +$9.00 (+75.00%).
- CANF annual EPS is now at all-time high.
Performance
CANF EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
N/A
June 30, 2024
Summary
- CANF quarterly earnings per share is not available.
Performance
CANF Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EPS
N/A
June 30, 2024
Summary
- CANF TTM earnings per share is not available.
Performance
CANF TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CANF EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | - | - |
| 3 y3 years | +75.0% | - | - |
| 5 y5 years | +94.1% | - | - |
CANF EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.7% | ||||
| 5 y | 5-year | at high | +92.9% | ||||
| alltime | all time | at high | +98.6% |
Can-Fite BioPharma EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$3.00(0.0%) | -$1.52(+252.5%) | -$3.00(+102.2%) |
| Sep 2023 | - | -$0.43(+6.4%) | -$1.48(-36.9%) |
| Jun 2023 | - | -$0.40(-37.7%) | -$2.35(-14.6%) |
| Mar 2023 | - | -$0.65(<-9900.0%) | -$2.75(-8.2%) |
| Dec 2022 | -$3.00(-66.7%) | $0.00(-100.0%) | -$3.00(-50.0%) |
| Sep 2022 | - | -$1.30(+61.2%) | -$6.00(-22.1%) |
| Jun 2022 | - | -$0.81(-10.0%) | -$7.70(-11.8%) |
| Mar 2022 | - | -$0.90(-70.2%) | -$8.73(-3.0%) |
| Dec 2021 | -$9.00(-25.0%) | -$3.00(0.0%) | -$9.00(+50.0%) |
| Sep 2021 | - | -$3.00(+63.4%) | -$6.00(+28.5%) |
| Jun 2021 | - | -$1.84(+57.7%) | -$4.67(-17.7%) |
| Mar 2021 | - | -$1.16(<-9900.0%) | -$5.67(-58.0%) |
| Dec 2020 | -$12.00(-71.4%) | $0.00(-100.0%) | -$13.51(-40.0%) |
| Sep 2020 | - | -$1.67(-41.2%) | -$22.51(-20.3%) |
| Jun 2020 | - | -$2.84(-68.4%) | -$28.23(-18.4%) |
| Mar 2020 | - | -$9.00(0.0%) | -$34.60(-8.0%) |
| Dec 2019 | -$42.00(-17.6%) | - | - |
| Dec 2019 | - | -$9.00(+21.8%) | -$37.60(-32.4%) |
| Sep 2019 | - | -$7.39(-19.7%) | -$55.60(+15.3%) |
| Jun 2019 | - | -$9.21(-23.3%) | -$48.21(+0.4%) |
| Mar 2019 | - | -$12.00(-55.6%) | -$48.00(-5.9%) |
| Dec 2018 | -$51.00(-10.5%) | - | - |
| Dec 2018 | - | -$27.00(<-9900.0%) | -$51.00(+30.8%) |
| Sep 2018 | - | $0.00(-100.0%) | -$39.00(-23.5%) |
| Jun 2018 | - | -$9.00(-40.0%) | -$51.00(-10.5%) |
| Mar 2018 | - | -$15.00(0.0%) | -$57.00(0.0%) |
| Dec 2017 | -$57.00(-36.7%) | - | - |
| Dec 2017 | - | -$15.00(+25.0%) | -$57.00(-25.1%) |
| Sep 2017 | - | -$12.00(-20.0%) | -$76.07(-14.4%) |
| Jun 2017 | - | -$15.00(0.0%) | -$88.88(+0.6%) |
| Mar 2017 | - | -$15.00 | -$88.34 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$90.00(+44.6%) | - | - |
| Dec 2016 | - | -$34.07(+37.3%) | -$90.00(+90.8%) |
| Sep 2016 | - | -$24.81(+71.6%) | -$47.17(-26.3%) |
| Jun 2016 | - | -$14.46(-13.2%) | -$64.00(-13.9%) |
| Mar 2016 | - | -$16.66(-290.3%) | -$74.36(+19.5%) |
| Dec 2015 | -$62.25(-40.1%) | - | - |
| Dec 2015 | - | $8.76(-121.0%) | -$62.25(-36.3%) |
| Sep 2015 | - | -$41.64(+67.8%) | -$97.69(+37.0%) |
| Jun 2015 | - | -$24.82(+445.6%) | -$71.33(-7.2%) |
| Mar 2015 | - | -$4.55(-82.9%) | -$76.86(-26.1%) |
| Dec 2014 | -$104.01(-43.0%) | - | - |
| Dec 2014 | - | -$26.68(+74.6%) | -$104.01(-27.7%) |
| Sep 2014 | - | -$15.28(-49.7%) | -$143.92(-9.4%) |
| Jun 2014 | - | -$30.35(-4.3%) | -$158.91(-5.0%) |
| Mar 2014 | - | -$31.70(-52.4%) | -$167.21(-15.5%) |
| Dec 2013 | -$182.63(+9.3%) | -$66.60(+120.0%) | -$197.92(+2.8%) |
| Sep 2013 | - | -$30.27(-21.7%) | -$192.49(-6.7%) |
| Jun 2013 | - | -$38.65(-38.1%) | -$206.39(+2.4%) |
| Mar 2013 | - | -$62.40(+2.0%) | -$201.47(-76.7%) |
| Dec 2012 | -$167.03(-22.1%) | - | - |
| Dec 2012 | - | -$61.16(+38.5%) | -$865.88(-22.6%) |
| Sep 2012 | - | -$44.17(+31.0%) | -$1119.26(+6.1%) |
| Jun 2012 | - | -$33.73(-95.4%) | -$1055.06(-0.9%) |
| Mar 2012 | - | -$726.81(+131.1%) | -$1065.13(+179.5%) |
| Dec 2011 | -$214.40(+69.0%) | - | - |
| Dec 2011 | - | -$314.54(-1670.5%) | -$381.15(+241.9%) |
| Sep 2011 | - | $20.03(-145.7%) | -$111.48(-35.4%) |
| Jun 2011 | - | -$43.81(+2.3%) | -$172.49(+34.0%) |
| Mar 2011 | - | -$42.83(-4.5%) | -$128.68(+49.9%) |
| Dec 2010 | -$126.83 | - | - |
| Dec 2010 | - | -$44.87(+9.5%) | -$85.85(+109.5%) |
| Sep 2010 | - | -$40.98 | -$40.98 |
FAQ
- What is Can-Fite BioPharma annual earnings per share?
- What is the all time high annual EPS for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual EPS year-on-year change?
- What is the all time high quarterly EPS for Can-Fite BioPharma?
- What is the all time high TTM EPS for Can-Fite BioPharma?
What is Can-Fite BioPharma annual earnings per share?
The current annual EPS of CANF is -$3.00
What is the all time high annual EPS for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual earnings per share is -$3.00
What is Can-Fite BioPharma annual EPS year-on-year change?
Over the past year, CANF annual earnings per share has changed by $0.00 (0.00%)
What is the all time high quarterly EPS for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly earnings per share is $20.03
What is the all time high TTM EPS for Can-Fite BioPharma?
Can-Fite BioPharma all-time high TTM earnings per share is -$1.48